U.S. Markets closed

  • S&P 500

    4,158.24
    +100.40 (+2.47%)
     

  • Dow 30

    33,212.96
    +575.77 (+1.76%)
     

  • Nasdaq

    12,131.13
    +390.48 (+3.33%)
     

  • Russell 2000

    1,887.86
    +49.62 (+2.70%)
     

  • Crude Oil

    115.12
    +1.03 (+0.90%)
     

  • Gold

    1,851.00
    +3.40 (+0.18%)
     

  • Silver

    22.13
    +0.16 (+0.75%)
     

  • EUR/USD

    1.0733
    0.0000 (-0.0000%)
     

  • 10-Yr Bond

    2.7430
    -0.0130 (-0.47%)
     

  • Vix

    25.72
    -1.78 (-6.47%)
     

  • GBP/USD

    1.2633
    +0.0028 (+0.2185%)
     

  • USD/JPY

    127.1000
    -0.0020 (-0.0016%)
     

  • BTC-USD

    28,906.71
    -487.85 (-1.66%)
     

  • CMC Crypto 200

    627.25
    -2.24 (-0.36%)
     

  • FTSE 100

    7,585.46
    +20.54 (+0.27%)
     

  • Nikkei 225

    26,781.68
    +176.84 (+0.66%)
     

Here's why PNC sees loan growth in 2022

Patty Tascarella
·3 min read
Here's why PNC sees loan growth in 2022
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • PNC

Pittsburgh bank's full-year guidance and investors call reveal strong expectations for newest territories.

Continue reading

Recommended Stories

  • Any Reason To Buy Canopy Growth Ahead Of Earnings?

    Canadian pot producer Canopy Growth in May said it planned to acquire Jetty Extracts. Is CGC stock a buy?

  • Trulieve Cannabis CEO buys $202,300 worth of stock

    Trulieve Cannabis CEO Kim Rivers acquired 14,000 shares of the cannabis company on Tuesday at a price of $14.45 a share for a total purchase value of about $202,300, according to a filing. Rivers now owns just under 2.5 million shares. Trulieve CFO Alex D'Amico acquired 1,500 shares and Trulieve president Steve White bought 7,000 shares. All told, Trulieve management bought 31,650 shares in recent days. Trulieve shares are down 2.9% in premarket trades. The stock has lost 45.7% of its value in 2

  • Why Novavax Is Up More Than 18% Today

    What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.

  • Dow Jones Rallies On Inflation Data; Tesla Pops As Elon Musk Issues This Warning; Apple Stock Surges

    The Dow Jones rallied amid encouraging inflation data. Tesla stock jumped even as CEO Elon Musk issued a warning. Apple stock surged.

  • Why Iovance Biotherapeutics Was Halved Today

    Shares of Iovance Biotherapeutics (NASDAQ: IOVA) are down 53% as of 12:24 p.m. ET Friday, according to data from S&P Global Market Intelligence, following the release of disappointing results from a pivotal melanoma drug trial released Thursday evening. Iovance had already reported solid results for melanoma treatment Lifileucel in the middle of last year, ultimately finding a response rate of 36%. This follow-on study of cancer patients with advanced melanoma who had shown improvement after previously receiving and responding to anti-PD-1/L1 therapies isn't as encouraging, with an objective response rate of only 29%.

  • Friday Is Going to Be a Big Day for Disney, Netflix, and AMC

    Theme parks, streaming services, and multiplexes are hoping the next few months are lucrative, and Walt Disney (NYSE: DIS), Netflix (NASDAQ: NFLX), and AMC Entertainment Holdings (NYSE: AMC) feel that there is no time like the present. A popular series is back with a new season -- part of a new season, anyway -- on Netflix. AMC hopes that the reboot of a classic action franchise will kick off a promising summer season.

  • 2 Renewable Energy Stocks to Buy and 1 to Avoid

    Despite all the attention that renewable energy companies get, having operations in the renewable energy space alone does not make a stock a buy. In fact, several renewable energy companies are struggling just to stay profitable. Let's discuss two renewable energy stocks that look attractive right now, and one that's best avoided.

  • Why Moderna Stock Is Jumping Today

    Shares of Moderna (NASDAQ: MRNA) were jumping 7.5% higher as of 11:30 a.m. ET on Friday. Instead, Moderna appears to be benefiting from the overall stock market bounce. Good news for the overall stock market tends to be good news for Moderna.

  • Why Amazon Stock Jumped Today

    Shareholders in Amazon (NASDAQ: AMZN) beat a rising market on Friday morning, with shares gaining 3% by 10:45 a.m. ET compared to a 1.4% boost in the S&P 500. The rally was powered by a brightening outlook around economic growth and consumer spending. A major factor driving Amazon's stock higher on Friday was the boost in the wider tech world.

  • Mirati Therapeutics Plunges As Its Hopes To Take On Amgen In Lung Cancer Crash

    Mirati is unlikely to carve out a share of the lung cancer market, analysts said Friday as MRTX stock collapsed on a testing disappointment.

  • Warren Buffett says these are the very best businesses to own — 3 high-quality examples from Berkshire's portfolio

    Stop investing in mediocre businesses. Buy the best, instead.

  • Stocks: ‘This is a rally in a bear market mode,’ strategist says

    Julian Bridgen, co-founder and president of Macro Intelligence 2 Partners, joins Yahoo Finance Live to discuss this week's market action and whether or not it will carry over into next week, the Fed, and inflation.

  • Why Dutch Bros Is Soaring 34% This Week

    Shares of Dutch Bros (NYSE: BROS) are rocketing higher this week, surging 34.1% compared to where they closed last Friday, according to data from S&P Global Market Intelligence, riding a meme stock wave of buying. After it was reported that short interest in the coffee shop shot up almost 30% in the latest period, stock traders who populate various internet stock chat rooms piled into the stock. Meme stocks, of course, are stocks that trade more on social media chatter than on business fundamentals, though in Dutch Bros' case the underlying business is pretty good, too.

  • Jim Cramer and Hedge Funds Agree on These 10 Stocks

    In this article, we discuss the 10 stocks that Jim Cramer and hedge funds agree on. If you want to read about some more stocks that Jim Cramer and hedge funds agree on, go directly to Jim Cramer and Hedge Funds Agree on These 5 Stocks. In the past few weeks, Jim Cramer, the journalist […]

  • Here's Why Farfetch Stock Is Soaring Today

    Shares of Farfetch Limited (NYSE: FTCH), a luxury fashion e-commerce platform, spiked today after the company reported a better-than-expected loss in the first quarter. Farfetch reported an adjusted loss per share of $0.24 in the first quarter, which was down from a loss of $0.22 per share in the year-ago quarter but ahead of analysts' average estimate of a loss of $0.28 per share. "Our core business remains very strong, in spite of the macro events in China and ceasing operations in Russia, which impacted our performance and outlook," José Neves, Farfetch's founder and CEO, said in a press release.

  • Why CrowdStrike, MongoDB, and Datadog Spiked Higher Today

    Shares of CrowdStrike (NASDAQ: CRWD), MongoDB (NASDAQ: MDB), and Datadog (NASDAQ: DDOG) all spiked on Friday, up 5.5%, 6.3%, and 7.2%, respectively, as of 1:22 p.m. EDT. The PCE differs from the Consumer Price Index (CPI) released earlier this month in that it weighs certain household expenditures differently and accounts for consumers substituting goods and services for other goods and services as relative prices change.

  • 10 Undervalued Stocks to Buy According to Billionaire Leon Cooperman

    In this article, we will look at 10 undervalued stocks to buy according to billionaire Leon Cooperman. If you want to skip reading about Leon Cooperman’s early life, investment philosophy, and his hedge fund’s performance, you can go directly to 5 Undervalued Stocks to Buy According to Billionaire Leon Cooperman. Leon Cooperman is an American […]

  • Ulta stock rises, Aurora Cannabis increases finance deal, Blackberry soars on Google partnership

    Ulta shares are up after its big Q1 earnings beat, Aurora Cannabis increased its finance deal to $150 million, and Blackberry stock is surging after news of its partnership with Google.

  • Canopy Growth’s Loss Was Bigger Than Feared. The Stock Is Falling Hard.

    The cannabis company's per-share loss was almost five times as big as analysts had expected. The stock plunged in response.

  • Billionaire Israel Englander Pulls the Trigger on These 2 ‘Strong Buy’ Penny Stocks

    Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th